Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
This study has been completed.
Study NCT00014989 Information provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First Received: April 17, 2001 Last Updated: November 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cerebral Palsy
Intraventricular Hemorrhage
Periventricular Leukomalacia
Pulmonary Edema
Abruptio Placentae
Additional conditions recognized in this trial
Cerebral Hemorrhage
Hemorrhage
Leukomalacia, Periventricular
More general conditions related to this trial
Brain Damage, Chronic
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Encephalomalacia
Infant, Newborn, Diseases
Infant, Premature, Diseases
Intracranial Hemorrhages
Lung Diseases
Nervous System Diseases
Obstetric Labor Complications
Pathologic Processes
Placenta Diseases
Pregnancy Complications
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
magnesium sulfate
More general drug interventions related to this trial
Analgesics
Anesthetics
Anti-Arrhythmia Agents
Anticonvulsants
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Sensory System Agents
Therapeutic Uses
Tocolytic Agents
Sponsors listed in this trial
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Neurological Disorders and Stroke (NINDS)
Back to top of Main Content
